A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
September 15, 2023
Video: Exela's Domestic Pharmaceutical Manufacturing Facility in Action
See how Premier, Exela® Pharma Sciences and Premier members are protecting the future of the pharmaceutical supply chain together.
September 15, 2023
Bridge the Gap: Conduct a <797> Gap Analysis to Extend BUDs
Pharmacy Purchasing & Products Magazine |
Premier's Kevin Hansen and Cone Health's Austin S. Price highlight how compounders can achieve longer beyond-use dates (BUDs) for compounded sterile preparations through enhanced quality...
August 31, 2023
Premier Comments on CMS Proposed Remedies for Reversing 340B Payment Cuts
Premier urged CMS to adopt policies to ensure that hospitals and other 340B entities are appropriately compensated for past 340B payment shortfalls.
August 30, 2023
Premier Comments on FDA Compounding Draft Guidance
Premier responded to the FDA’s draft guidance on the statutory prohibition on wholesaling for certain compounded drugs.
August 24, 2023
A Look Inside Exela's Domestic Pharmaceutical Manufacturing Facility
The Premier team, member hospitals, and government and community leaders visit Exela's facility in Lenoir, NC.
August 16, 2023
Premier Responds to CMS RFI on Bundled Payments
Premier submitted comments to CMS on the design of a potential new episode-based payment model aimed at improving care, lowering costs and increasing care coordination.
August 08, 2023
Premier Weighs in with FDA on Using Artificial Intelligence and Machine Learning in Drug Development
Premier outlines ways that FDA can best incorporate emerging technologies into drug development and provide clarity for clinical trial innovators.
July 27, 2023
Statement on the Introduction of the Value in Health Care Act
Premier applauds the introduction of legislation to support providers' efforts to advance value-based care.
July 27, 2023
Premier Responds to Congressional 340B RFI
Premier urges Congress to take action to improve the 340B program to allow safety net providers continued access to discounted drug prices.
July 17, 2023
Endo and Premier, Inc. Collaborate to Address Pitocin® (oxytocin injection, USP) Shortage
Endo’s Par Sterile Products business will supply Pitocin® vials through Premier’s ProvideGx® and PremierProRx® programs.
July 07, 2023
Statement on CMS' Proposed Remedy for the 340B-Acquired Drug Payment Policy
Premier responds to the proposed rule on recoupment of underpayments to 340B covered entities as a result of last summer’s Supreme Court decision.
July 07, 2023
Premier Offers Congress Policy Solutions to Eliminate Drug Shortages
Premier calls for greater legislative, regulatory and oversight action to address persistent drug shortages.
